title: Cancer nanomedicines: closing the translational gap.
authors.affiliation: Shaare Zedek Medical Center and Hebrew University-School of Medicine, Jerusalem, Israel.
authors.forename: Alberto
authors.initials: A
authors.lastname: Gabizon
authors.affiliation: Sloan Kettering Institute for Cancer Research and Weill Medical College of Cornell University, New York, NY, USA.
authors.forename: Michelle
authors.initials: M
authors.lastname: Bradbury
authors.affiliation: Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, MD 20892, USA.
authors.forename: Uma
authors.initials: U
authors.lastname: Prabhakar
authors.affiliation: UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
authors.forename: William
authors.initials: W
authors.lastname: Zamboni
authors.affiliation: Albert Einstein College of Medicine, New York, NY, USA.
authors.forename: Steven
authors.initials: S
authors.lastname: Libutti
authors.affiliation: Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: grodzinp@mail.nih.gov.
authors.forename: Piotr
authors.initials: P
authors.lastname: Grodzinski
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics; D016503:Drug Delivery Systems; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007880:Legislation, Drug; D050997:Nanomedicine; D009369:Neoplasms / Q000188:drug therapy*; D057285:Precision Medicine
chemical_list: D000970:Antineoplastic Agents